생명과학 소프트웨어 시장 규모, 점유율, 성장 분석 : 전개별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Life Sciences Software Market Size, Share, and Growth Analysis, By Deployment (Cloud, On-premise), By Application (Preclinical and Clinical Trials, Supply chain management), By End-user, By Region - Industry Forecast 2025-2032
상품코드:1670361
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 195 Pages
라이선스 & 가격 (부가세 별도)
한글목차
생명과학 소프트웨어 세계 시장 규모는 2023년 147억 달러로 평가되며, 예측 기간(2025-2032년) 동안 12.3%의 CAGR로 2024년 165억 1,000만 달러에서 2032년 417억 6,000만 달러로 성장할 것으로 예상됩니다.
생명과학 소프트웨어 시장은 제약, 생명공학, 의료기기 분야의 기업들이 업무, 연구, 규제 준수를 위해 전용 애플리케이션에 대한 의존도가 높아짐에 따라 크게 성장하고 있습니다. 이 시장에는 임상시험 정보 관리 시스템(LIMS), 임상시험 관리 시스템(CTMS), 전자 실험 노트(ELN) 등 다양한 솔루션이 포함됩니다. 디지털화와 자동화의 급격한 증가와 더불어 정밀의료에 대한 관심과 바이오의약품 연구의 확대가 수요를 견인하고 있습니다. 또한, R&D의 빠른 시장 출시와 생산성 향상에 대한 요구는 통합적이고 확장 가능한 솔루션에 대한 수요를 강조하고 있습니다. 전반적으로, 개인화 및 의료 서비스 제공의 개선 추세는 생명과학 소프트웨어를 현대 의료 및 생명공학 산업에서 매우 중요한 요소로 더욱 확고히 자리매김하고 있습니다.
목차
소개
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 가정과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porters 분석
주요 시장 인사이트
핵심성공요인
경쟁 정도
주요 투자 기회
시장 생태계
시장 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
기술의 진보
사례 연구
특허 분석
규제 분석
생명과학 소프트웨어 시장 규모 : 전개별 & CAGR(2025-2032년)
시장 개요
클라우드
온프레미스
생명과학 소프트웨어 시장 규모 : 용도별 & CAGR(2025-2032년)
시장 개요
전임상 및 임상시험
공급망 관리
연구개발
상업적 참여와 브랜딩
의약품 안전성 감시
규제 준수
생명과학 소프트웨어 시장 규모 : 최종사용자별 & CAGR(2025-2032년)
시장 개요
바이오테크놀러지 및 제약 기업
의료 연구 센터
의료기기 기업
기타
생명과학 소프트웨어 시장 규모 : 지역별 & CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5개사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
최근의 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년비 비교(2022-2024년)
주요 기업 개요
Veeva Systems(United States)
IQVIA(United States)
Schrodinger, Inc.(United States)
Accenture(Ireland)
SAS Institute(United States)
Oracle Corporation(United States)
Microsoft Corporation(United States)
IBM(United States)
PerkinElmer(United States)
Thermo Fisher Scientific(United States)
Benchling(United States)
ArisGlobal(United States)
Medidata Solutions(United States)
BioClinica(United States)
PAREXEL International(United States)
Dassault Systemes(France)
IDBS(United Kingdom)
LabWare(United States)
Schrodinger(United States)
Exscientia(United Kingdom)
결론과 제안
ksm
영문 목차
영문목차
Global Life Sciences Software Market size was valued at USD 14.7 billion in 2023 and is poised to grow from USD 16.51 billion in 2024 to USD 41.76 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).
The life sciences software market is experiencing significant growth as organizations in the pharmaceutical, biotechnology, and medical device sectors increasingly rely on specialized applications for operations, research, and regulatory compliance. This market encompasses a variety of solutions, including laboratory information management systems (LIMS), clinical trial management systems (CTMS), and electronic lab notebooks (ELN). The surge in digitization and automation, coupled with the focus on precision medicine and the expansion of biopharmaceutical research, is driving demand. Additionally, the need for quicker time-to-market and enhanced productivity in research and development emphasizes the demand for integrated, scalable solutions. Overall, the trend towards personalization and improved healthcare delivery further solidifies life sciences software as a pivotal component in modern healthcare and biotech industries.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Life Sciences Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Life Sciences Software Market Segments Analysis
Global Life Sciences Software Market is segmented by Deployment, Application, End-user and region. Based on Deployment, the market is segmented into Cloud and On-premise. Based on Application, the market is segmented into Preclinical and Clinical Trials, Supply chain management, Research and Development, Commercial Engagement and Branding, Pharmacovigilance and Regulatory Compliance. Based on End-user, the market is segmented into Biotechnology and Pharmaceutical Companies, Medical Research Centers, Medical Device Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Life Sciences Software Market
One of the primary drivers fueling the growth of the Global Life Sciences Software market is the increasing pressure to expedite drug development pipelines. In light of urgent global health challenges, including pandemics and chronic diseases, pharmaceutical firms and research organizations are compelled to enhance the speed at which they identify, develop, and deliver new therapeutics. Life sciences software plays a critical role in this process by facilitating more efficient data management, analysis, and collaboration throughout the entire drug development lifecycle. As these health challenges continue to evolve, the demand for innovative software solutions within the life sciences sector is expected to rise significantly.
Restraints in the Global Life Sciences Software Market
One significant hindrance in the Global Life Sciences Software market is the high expense associated with these software solutions. The financial burden extends beyond mere purchase or subscription fees and encompasses additional costs related to integration, customization, training, and ongoing support. This can pose considerable challenges, especially for small to medium-sized enterprises (SMEs) and academic institutions, whose budgets may not accommodate such substantial investments. As a result, these financial constraints can severely limit their ability to adopt and effectively implement advanced software tools, thereby impeding their growth and innovation within the life sciences sector.
Market Trends of the Global Life Sciences Software Market
The Global Life Sciences Software market is experiencing significant growth driven by the incorporation of Artificial Intelligence (AI) and Machine Learning (ML). These advanced technologies are revolutionizing various facets of life sciences, including drug development, clinical trials, and patient diagnostics. By enabling the rapid analysis of vast datasets, AI and ML facilitate the discovery of valuable insights and patterns that enhance research efficacy and treatment strategies. This trend is not only streamlining processes but also fostering innovation, ultimately leading to improved healthcare outcomes and personalized medicine. As the adoption of AI and ML continues to rise, the life sciences software market is poised for robust expansion.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Case Studies
Patent Analysis
Regulatory Analysis
Global Life Sciences Software Market Size by Deployment & CAGR (2025-2032)
Market Overview
Cloud
On-premise
Global Life Sciences Software Market Size by Application & CAGR (2025-2032)
Market Overview
Preclinical and Clinical Trials
Supply chain management
Research and Development
Commercial Engagement and Branding
Pharmacovigilance
Regulatory Compliance
Global Life Sciences Software Market Size by End-user & CAGR (2025-2032)
Market Overview
Biotechnology and Pharmaceutical Companies
Medical Research Centers
Medical Device Companies
Others
Global Life Sciences Software Market Size & CAGR (2025-2032)
North America (Deployment, Application, End-user)
US
Canada
Europe (Deployment, Application, End-user)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Deployment, Application, End-user)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Deployment, Application, End-user)
Brazil
Rest of Latin America
Middle East & Africa (Deployment, Application, End-user)
